Form 8-K - Current report:
SEC Accession No. 0001079973-25-000738
Filing Date
2025-05-02
Accepted
2025-05-02 16:15:25
Documents
13
Period of Report
2025-04-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 24871
  Complete submission text file 0001079973-25-000738.txt   193120

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scpx-20250428.xsd EX-101.SCH 3099
3 XBRL LABEL FILE scpx-20250428_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE scpx-20250428_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 3359
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25908743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)